Earnings call Dr. Lal PathLabs reported 10.7% YoY revenue growth and 19.3% PAT growth in Q3 FY25, despite no price increases. The company is executing a multi-pronged strategy of geographic expansion, ...
Care Ratings expects Dr Lal PathLabs' revenue to grow by 11-12 per cent per annum in the near-to-medium term driven by ...
Dr. Lal Path Labs hits a 52-week high driven by Dubai expansion, strong FY27 growth guidance, solid earnings performance, and ...
Discover Dr Lal Path Labs diagnostic services in New Delhi, Delhi. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information on ...
Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...
Bengaluru: Dr. Lal Path Labs reported a ‍lower third-quarter profit on Friday after taking a one-time charge ⁠linked to India's new labour code, despite strong demand for its bundled test packages.
Discover Dr Lal Path Labs diagnostic services in Indore, Madhya Pradesh. Get directions and view its location on an interactive map. Search our database by state, city, or pincode to find information ...
When my father, Dr SK Lal, decided to make India his country at the time of Partition, and came to Delhi from Rawalpindi, he had 31 dependents with him," recalls (Hony) Brigadier Dr Arvind Lal, ...
(Reuters) - Dr. Lal PathLabs, India's top diagnostics firm by revenue, reported a bigger-than-expected second-quarter profit on Wednesday, driven by continued demand and a rising awareness for health ...
Bengaluru: Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid ...
Earnings call Dr. Lal PathLabs delivered Q3 FY26 revenue growth of 10.6% YoY to INR 660 crore, with EBITDA before exceptionals up 16.3% and a margin of 27.2%. Patient volume growth was modest at 2.7% ...